Basic Information
MitoSense, Inc. is a company dedicated to developing treatments for neurodegenerative diseases. Through its research partners based in the United States, the company holds exclusive licensing technology for supplementing human mitochondria using Mitochondrial Organelle Transplantation (MOT™️).
MitoSense, Inc.
Virginia,United States of America
less than 15 people
January 01, 2019
info@mitosenseinc.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios